z-logo
open-access-imgOpen Access
Normal Immunoglobulin (Human) 10% and Recombinant Human Hyaluronidase (HyQvia)
Author(s) -
CADTH
Publication year - 2022
Publication title -
canadian journal of health technologies
Language(s) - English
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2022.415
Subject(s) - reimbursement , hyaluronidase , recombinant dna , antibody , medicine , drug , human immunodeficiency virus (hiv) , immunology , pharmacology , chemistry , enzyme , political science , biochemistry , health care , law , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom